Concepedia

Melanie Mackean

MM

Statistics

Publications

38

Citations

3.1K

H-Index

25

Active since

1998

Affiliations

Western General Hospital(Current)

Edinburgh Cancer Research

Beatson West of Scotland Cancer Centre

University of Edinburgh

Institute of Genetics and Cancer

Melanie Mackean is an author at Western General Hospital specializing in medicine, oncology, and ovarian cancer.

ORCID

Publications per year

1998–2025

38

Publications

38

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Antonio Passaro, Jing Wang, Yan Wang et al. · Annals of Oncology · 2023 · 396 citations · Full text

, , +17

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

Gordon Strathdee, Melanie Mackean, Maureen Illand et al. · Oncogene · 1999 · 352 citations

, , +17

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

Justin S. Waters, A. Norman, David Cunningham et al. · British Journal of Cancer · 1999 · 278 citations · Full text

, , +15

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

Melanie Mackean, André Planting, Chris Twelves et al. · Journal of Clinical Oncology · 1998 · 268 citations

, , +15

Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor–Positive Patients

John F. Smyth, Charlie Gourley, Graeme E. Walker et al. · Clinical Cancer Research · 2007 · 190 citations · Full text

, , +17

1–5 of 38